Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
JAMA Dermatology|April 14, 2021
Long-term Outcomes and Prognosis in New-Onset PsoriasisAxel Svedbom, Lotus Mallbris, Per Larsson, et al.Clinical and Experimental Dermatology|October 11, 2023
Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studiesMark Lebwohl, Lars Iversen, Liv Eidsmo, et al.The Journal of Investigative Dermatology|March 18, 2011
MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2Ning Xu, Petter Brodin, Tianling Wei, et al.JAMA Dermatology|November 26, 2025
Hidradenitis Suppurativa Remission and Progression in a Community SettingRune Kjærsgaard Andersen, Morten Kranker Larsen, Ole Birger V Pedersen, et al.Acta Dermato-Venereologica|June 1, 2026
Psoriasis Triggers and Disease Activity: Analysis of Survey Data from the PSODEEP1 StudyAlbert Duvetorp, Juul van den Reek, Juni Wikström, et al.The Journal of Investigative Dermatology|March 7, 2018
Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical OutcomeIrène Gallais Sérézal, Cajsa Classon, Stanley Cheuk, et al.Immunity|July 25, 2023
Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretationAnthonie Johan Zwijnenburg, Jyoti Pokharel, Renata Varnaitė, et al.Plos Neglected Tropical Diseases|October 23, 2010
Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulcerationGeremew Tasew, Susanne Nylén, Thorsten Lieke, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 6, 2023
Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn studyLars Iversen, Curdin Conrad, Liv Eidsmo, et al.European Journal of Immunology|October 10, 2023
The cellular microenvironment regulates CX3CR1 expression on CD8+ T cells and the maintenance of CX3CR1+ CD8+ T cellsJyoti Pokharel, Iman Shryki, Anthonie J Zwijnenburg, et al.Pageof 7